Lido Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Lido Advisors's BIIB Position: Q3 2026 in Review
Lido Advisors reduced its Biogen (BIIB) stake by 23% in Q3 2026, selling an estimated $256K and leaving 4,086 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.
Lido Advisors first reported a position in BIIB in Q2 2021 and has held it in 15 quarters since. The position peaked at $6.36M in Q4 2024. 901 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Lido Advisors held 4,086 shares of Biogen worth $923K as of Q3 2026.
- Lido Advisors sold 1,206 Biogen shares in Q3 2026, an estimated $256K.
- Biogen made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #1132 holding.
- Lido Advisors first reported a position in Biogen in Q2 2021 and has held it in 15 quarters since.
- Lido Advisors's Biogen position peaked at $6.36M in Q4 2024.
- 901 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.